Interdigital Tinea Pedis

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

DermBiont
DermBiontMA - Boston
1 program
1
Cohort 1 J. LividumPhase 21 trial
Active Trials
NCT04315051Terminated39Est. Jun 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
DermBiontCohort 1 J. Lividum

Clinical Trials (1)

Total enrollment: 39 patients across 1 trials

NCT04315051DermBiontCohort 1 J. Lividum

A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis

Start: Sep 2019Est. completion: Jun 202039 patients
Phase 2Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space